Stock MGNX MACROGENICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News MacroGenics, Inc.

Equities

MGNX

US5560991094

Real-time Estimate Cboe BZX
Other stock markets
 11:28:01 2024-07-05 am EDT 		5-day change 1st Jan Change
4.21 USD +0.24% Intraday chart for MacroGenics, Inc. -0.93% -56.23%
Jun. 24 MacroGenics, Inc.(NasdaqGS:MGNX) dropped from S&P Biotechnology Select Industry Index CI
Jun. 13 Transcript : MacroGenics, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-13-2024 10:00 AM

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
MacroGenics, Inc.(NasdaqGS:MGNX) dropped from S&P Biotechnology Select Industry Index
CI
Transcript : MacroGenics, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-13-2024 10:00 AM
MacroGenics to Participate in Upcoming Investor Conference
GL
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against MacroGenics, Inc. and Encourages Investors to Contact the Firm
PR
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against MacroGenics, Inc. (MGNX)
BU
MacroGenics to Participate in Upcoming Investor Conferences
GL
Sector Update: Health Care Stocks Higher Late Afternoon
MT
Sector Update: Health Care
MT
Top Midday Decliners
MT
Sector Update: Health Care Stocks Edge Higher Premarket Friday
MT
Wall Street Set to Extend Gains on Thursday's Higher-Than-Expect Jobless Claims Report, Lifting US Equity Futures Pre-Bell
MT
Top Premarket Decliners
MT
BMO Downgrades MacroGenics to Market Perform From Outperform, Price Target at $8
MT
Stifel Downgrades MacroGenics to Hold
MT
TD Cowen Downgrades MacroGenics to Hold From Buy
MT
MacroGenics Says Five Patients Died in Cancer Study
MT
MacroGenics Q1 Loss Widens, Revenue Falls
MT
MacroGenics : TAMARACK Phase 2 Interim Data (April 12, 2024 data cut-off)
PU
Transcript : MacroGenics, Inc., Q1 2024 Earnings Call, May 09, 2024
Earnings Flash (MGNX) MACROGENICS Posts Q1 Revenue $9.1M, vs. Street Est of $14.9M
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MGNX Stock
  4. News MacroGenics, Inc.